MedPath

A Clinical Trial to study the Effect of Daily Abhyanga with Balaswagandha Lakshadi taila in Response Inhibition among Children with Hyperactivity.

Phase 3
Conditions
Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
Registration Number
CTRI/2024/01/060989
Lead Sponsor
Dr Arathi M Nair
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Screened for hyperactivity using Conner Abbreviated Teacher Rating scale and selected subjects who has a score above 15

Consent from Parents / Guardian.

Assent.

Exclusion Criteria

Children who are under medication for epilepsy.

Children who have asthma and experience repeated or frequent episodes of asthma attacks.

Children with skin disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
•Response inhibition.Timepoint: • At baseline, 3 months
Secondary Outcome Measures
NameTimeMethod
HyperactivityTimepoint: at baseline, 3 months
© Copyright 2025. All Rights Reserved by MedPath